Neil joined Magnetar Capital in May 2021 as a founding member of Magnetar’s Venture Healthcare strategy. Prior to Magnetar, since 2019 Neil was Managing Director, dRx Capital for Novartis. Neil represented dRx Capital as its leader and was responsible for overseeing, managing, and mentoring the additional Investment Managers that comprised the dRx Capital team. Neil oversaw and completed multiple investments and sat on multiple boards. Lastly, he was responsible for overall fund oversight, performance, reporting, compliance, and governance. Prior to this role, Neil served as a Principal in the fund since 2017. Neil started his career as a product development engineer in 2006 and led complex engineering teams on development and launch of 10 medical devices and software products and is an inventor on 13 patents from his work in this space. Additionally, Neil is currently a board director at Cala Health & Mekonos, an independent board director at Science 37, and a board observer at Enable Injections. Neil has a BS & MS in Biomedical Engineering from Northwestern University & an MBA from the Haas School of Business at Berkeley.